Saturday, January 22, 2022

Thursday, 7 December 2017
Divani Caravel Hotel,
Athens, Greece


Thursday, December 7, 2017

08:30 - 09:00


09:00 - 09:30

Introductory Speeches:

  • George Giannopoulos, Secretary General, Ministry of Health
  • Sotirios Bersimis, President of the National Organization for the Provision of Healthcare Services (EOPYY)
  • Katerina Antoniou, President of Greek Organization for Medicines (EOF)
SESSION 1 | Policy Developments on Medicine Pricing Structures: Challenges & Opportunities
09:30 - 11:00


    Despoina Makridaki, A' Vice President National Organization of Medicines (EOF), President of the Pan-Hellenic Association of Hospital Pharmacists (PEFNI)
Keynote Speech

"Evolution of new pricing strategies"

Entela Xoxi, PharmD, PhD, MSci, Independent Consultant, Senior Regulatory & Health Policy Advisor, Former AIFA' Registries Co-Ordinator

"Pricing & Reimbursement: The Portuguese Experience"

Helder Mota-Filipe, Associate Professor of Social Pharmacy, Faculty of Pharmacy, University of Lisbon, Portugal

"Policy Developments on the National Pricing Policy"

Ioannis Podimatas, Special Advisor to the Secretary General, Ministry of Health

"Fact based preparation for Policy & Pricing Development"

Nikos Kostaras, General Manager, IQVIA TM

"The Social Impact of innovations: An approach "beyond" the current pricing and reimbursement policy"

Dennis Ostwald, CEO WifOR


11:00 - 11:30

Coffee break

Keynote Speeches: Pricing, Reimbursement & Electronic Prescription
11:30 - 12:00

Can HDIKA's Infrastructure Support Big Data?

    Anastasios Tagaris, President and CEO, HDIKA

The importance of Patient Registries Data for Evidence-based Policy Making

    Eleftherios Thiraios, General Secretary, Athens Medical Society
SESSION 2 | New Reimbursement Framework in Relation to the Healthcare System's Sustainability
12:00 - 13:30


    Nikos Polyzos, Professor, Department of Social Administration and Political Science, Democritus University of Thrace

"The Vision towards an Effective Introduction of an HTA Body in Greece"

Dimitrios Kouvelas, Professor and Head of the Dept. of Clinical Pharmacology School of Medicine, Aristotle University of Thessaloniki

"Registry of EOPYY- EKAPTY Medical Devices"

Theofanis Rigatos, Head of Strategic Planning, General Directorate for the Organization and Planning of Health Services Purchasing, National Organization for Health Services (EOPYY)

"Lessons from Reimbursement Systems around Europe"

Zoi Stefanidou, Head International Market Access, Elpen Pharmaceutical Co. Inc., Vice - President, Hellenic Association of Pharmaceutical Management

"The Reimburser's Dilemma: 4 Scenarios of Economic Context"

Athanassios Vozikis, Assistant Professor, Director of the Laboratory of Health Economics and Management, Economics Dept., School of Economics, Business and International Studies, University of Piraeus

"Reimbursement: From medical assessment to HTA"

Magda Chatzikou, PhD, Managing Partner, PharmEcons Easy Access Ltd


13:30 - 14:30

Lunch Break

SESSION 3 | Patient Affordability: Bridge the Gap between Access and the Patient's Pocket
14:30 - 15:15


    George Tsiakalakis, Advocacy and Communications Officer, 'Positive Voice' Hellenic Association of HIV/AIDS

"Patient Spending: Perceptions & Reality"

Ioannis Gkouvitsos, Consultant, IQVIA TM

"The WHO's global report on psoriasis. Advocacy actions for psoriatic patients in Greece"

Leonidas Fotiadis, Treasurer of Panhellenic Association of Patients with Psoriasis and Psoriatic Arthritis EPIDERMIA . President of Panhellenic Association of Patients with Autoimmune Rheumatic Diseases AKESO - Board Member of Panhellenic Federation Reumazein

"New game, new rules: The affordability debate in Europe"

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines, European Public Health Alliance (EPHA), Brussels


15:15 – 15:30
Keynote Speech

"Are pharmaceuticals all equal? The case of blood plasma derived medicinal products and rare disease medicines"

Bruno Santoni, Executive Director, Plasma Protein Therapeutics Association (PPTA) Europe

Is There Room for Sustainable Financing and Efficient Operation of the Health System in an Environment under Austerity and Fiscal Consolidation?
15:30 - 17:00
Roundtable Discussion


    Dimitris Pantazis, CEO, Institute of Pharmaceutical Research & Technology (IFET)
  • Ilias Giannoglou, B΄ Vice President, National Organization for Medicines (EOF)
  • Panagiotis Georgakopoulos, Vice President, National Organization for the Provision of Healthcare Services (EOPYY)
  • Dimitris Pantazis, CEO, Institute of Pharmaceutical Research & Technology (IFET)
  • Vasileios Pentafragas, Executive Director, Panhellenic Union of Pharmaceutical Industry (PEF)
  • Makis Papataxiarchis, Managing Director, Janssen Greece, Pharmaceutical Companies of Johnson & Johnson, President, PhRMA Innovation Forum & Chairman, AMCHAM Pharma Committee
17:00 - 17:15

Concluding Remarks


© 2022 Boussias Communications, all rights reserved., T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team